Barclays PLC Milestone Pharmaceuticals Inc. Transaction History

Barclays PLC

$288 Billion
Q1 2024

A detailed history of Barclays PLC transactions in Milestone Pharmaceuticals Inc. stock. As of the latest transaction made, Barclays PLC holds 100 shares of MIST stock, worth $150. This represents 0.0% of its overall portfolio holdings.

Number of Shares

100

Previous 255,185 99.96%

Holding current value

$150

Previous $426,000 100.0%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$1.4 - $2.2 $357,119 - $561,187	-255,085 Reduced 99.96%	100 $0
Q4 2023 Feb 15, 2024	SELL	$1.67 - $3.39 $651,809 - $1.32 Million	-390,305 Reduced 60.47%	255,185 $426,000
Q3 2023 Nov 07, 2023	SELL	$2.68 - $3.69 $416,166 - $573,005	-155,286 Reduced 19.39%	645,490 $2 Million
Q2 2023 Aug 03, 2023	SELL	$2.85 - $4.4 $131,248 - $202,628	-46,052 Reduced 5.44%	800,776 $2.28 Million
Q1 2023 May 04, 2023	BUY	$3.14 - $4.2 $645,191 - $862,995	205,475 Added 32.04%	846,828 $3.34 Million

Q4 2022 Feb 13, 2023	BUY	$3.53 - $5.02 $355,721 - $505,870	100,771 Added 18.64%	641,353 $2.54 Million
Q3 2022 Nov 03, 2022	BUY	$5.86 - $9.43 $1.93 Million - $3.1 Million	328,872 Added 155.34%	540,582 $4.97 Million
Q2 2022 Aug 12, 2022	SELL	$5.13 - $7.37 $76,950 - $110,550	-15,000 Reduced 6.62%	211,710 $1.3 Million
Q1 2022 May 16, 2022	BUY	$4.1 - $8.24 $97,157 - $195,263	23,697 Added 11.67%	226,710 $1.46 Million
Q4 2021 Feb 14, 2022	BUY	$5.47 - $7.13 $12,717 - $16,577	2,325 Added 1.16%	203,013 $1.33 Million
Q3 2021 Nov 09, 2021	SELL	$5.28 - $6.29 $16,964 - $20,209	-3,213 Reduced 1.58%	200,688 $1.15 Million
Q2 2021 Aug 13, 2021	BUY	$5.22 - $6.11 $245,470 - $287,322	47,025 Added 29.98%	203,901 $1.12 Million
Q1 2021 May 13, 2021	BUY	$5.79 - $8.85 $692,258 - $1.06 Million	119,561 Added 320.41%	156,876 $909,000
Q2 2020 Aug 12, 2020	BUY	$1.77 - $4.56 $65,960 - $169,932	37,266 Added 76053.06%	37,315 $141,000
Q1 2020 May 13, 2020	SELL	$1.7 - $22.5 $1,446 - $19,147	-851 Reduced 94.56%	49 $0
Q4 2019 Feb 10, 2020	BUY	$15.4 - $21.9 $13,860 - $19,710	900 New	900 $14,000

Others Institutions Holding MIST

# of Institutions

Shares Held

31.3M

Call Options Held

3.3K

Put Options Held

3.5K

View Full List

About Milestone Pharmaceuticals Inc.

Ticker MIST
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,010,900
Market Cap $45M
Description
Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. The company is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada; and Phase II cl...

More about MIST

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account